Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02780206
Other study ID # IRB2016-0304
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2016
Est. completion date October 2018

Study information

Verified date February 2022
Source Texas A&M University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Understanding how foods and nutrients are digested, absorbed and metabolized when weight is stable and during weight loss induced by very low calorie diet procedure using the technologies of genomics, transcriptomics, proteomics, metabolomics and fluxomics ("omics") will enable generation of new hypotheses that could explain the inter-individual differences in weight loss and could lead to optimization and individualization of therapies designed to lose weight.


Description:

The overarching hypothesis is that there are baseline, pre- and post-diet combinations of 'omics' signatures in response to food and nutrients that explain the weight loss response of obese subjects to the very low calorie (VLC) diet. In order to address the general hypothesis the following specific aims will be addressed: Specific Aim 1: To test the hypothesis that there is a combination of 'omics' parameters in response to a defined meal that discriminate between morbidly obese subjects. Specific Aim 2: To test the hypothesis that variation in % weight loss to the 2-weeks of VLC diet is related to baseline genomic markers, gene expression profile, proteomic and metabolomic signatures as well as baseline metabolic and substrates fluxomics response to a defined meal. Specific Aim 3: To test the hypothesis that variation in % weight loss to the 4-weeks of VLC diet is related to baseline genomic markers, gene expression profile, proteomic and metabolomic signatures as well as baseline metabolic and substrates fluxomics response to a defined meal.


Recruitment information / eligibility

Status Completed
Enrollment 56
Est. completion date October 2018
Est. primary completion date October 2018
Accepts healthy volunteers No
Gender All
Age group 30 Years and older
Eligibility Inclusion criteria obese subjects: Diagnosed with morbid obesity (defined as BMI > 40 kg/m2 or BMI > 35 kg/m2 with at least one serious comorbidity (2013 NIH compendium guidelines)) Scheduled for medically supervised Very Low Calorie Diet Age 30 years and older Ability to lay in supine or elevated position for 5 hours Willingness and ability to comply with the protocol Exclusion Criteria Any condition that may interfere with the definition 'healthy subject' according to the investigator's judgment (for healthy control group only) Participation in Weight Loss Management Program within the last 6 months prior the first study day Presence of fever within the last 3 days Untreated metabolic diseases including hepatic or renal disorder unrelated to the primary disease Presence of acute illness or metabolically unstable chronic illness unrelated to the primary disease ยท (Possible) pregnancy Any other condition according to the PI or nurse that would interfere with the study or safety of the patient Failure to give informed consent Use of protein or amino acid containing nutritional supplements within 3 days of first test day

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Stable isotope amino acid infusion
such as glycerol, D2O, tyrosine, phenylalanine, glucose, arginine, and citrulline

Locations

Country Name City State
United States Texas A&M University-CTRAL College Station Texas

Sponsors (1)

Lead Sponsor Collaborator
Texas A&M University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in net whole-body protein synthesis Change in whole-body protein synthesis rate after intake of meal 0, 2, 5, 10, 15, 20, 30, 40, 50, 60, 90, 120, 150, 180, 210, 225, 240, 260, 280, 300, 320, 340, 360 ± 5 min
Secondary Group differences in state of mood as measured by the Hospital Anxiety and Depression Scale (HADS) a fourteen item self-assessment scale. Seven of the items related to anxiety and seven relate to depression. Each item on the questionnaire is scored from 0-3 and this means that a person can score between 0 (no symptoms) and 21 (severe symptoms) for either anxiety or depression. Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
Secondary Executive Function-Adolescent/Adult Sensory Profile (ASP) a standardized self-questionnaire that generates an individualized profile of sensory processing across four quadrants: low registration, sensation seeking, sensory sensitivity, and sensation avoiding. Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
Secondary Group differences in quality of life as measured by Short Form (36) Health Survey (SF36) self administered questionnaire that measures each of the following eight health concepts: Physical Functioning (PF); Role-Physical (RP); Bodily Pain (BP); General Health (GH); Vitality (VT); Social Functioning (SF); Role-Emotional (RE); Mental Health (MH) as well as a reported Health Transition item (HT) Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
Secondary Group differences in activity as measured by Physical Activity Scale for the Elderly (PASE) questionnaire is intended for use in an elderly population and focuses on 3 types of activities: leisure time activities, household activities and work-related activities. Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
Secondary Group differences in attention and executive functions as measured by Stroop Color-Word Test (SCWT) a word page with words printed in black ink, a color page with blocks printed in color, and a color-word page where the color and the word do not match. The examinee reads the words or names the ink colors as quickly as possible within a time limit. Measures selective attention and inhibitory control. The total time in seconds was reported for each trial. Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
Secondary Group differences in state of mood as measured by the Profile of Mood State (POMS) A psychological distress scale to measure mood disturbance in 6 domains - fatigue-inertia, vigor-activity, tension-anxiety, depression-dejection, anger-hostility, and confusion-bewilderment. Healthy populations take 3 to 7 minutes to complete, and others may take up a bit longer. Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
Secondary Group differences in learning and memory as measured by Controlled Oral Word Association Test (COWAT) Controlled Oral Word Association Test (COWAT): The examinee is required to say as many words as they can think of in one minute that begin with a given letter of the alphabet. The task contains three trials. Measures phonetic verbal fluency. The raw score (total and mean words recorded across the three trials) was reported. Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
Secondary Group differences in learning and memory as measured by Auditory Verbal Learning Test (AVLT) Auditory Verbal Learning Test (AVLT): a verbal episodic memory test that evaluates a wide diversity of functions: short-term auditory-verbal memory, rate of learning, retention and recognition of information Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
Secondary Group differences in attention and executive functions as measured by PASAT a measure of cognitive function that assesses auditory information processing speed and flexibility, as well as calculation ability. Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
Secondary Group differences in attention and executive functions as measured by Trail Making Test (TMT) In Part A, the examinee is instructed to connect a set of 25 circles with numbers as quickly as possible while maintaining accuracy. In Part B, the examinee is instructed to connect a set of 25 circles, alternating between numbers and letters, as quickly as possible while maintaining accuracy. Measures attentional resources and is a measure of the frontal lobe "executive" functions of visual search, set-switching and mental flexibility. The total time in seconds was reported for each measure. Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
Secondary Group differences in overall cognitive abilities as measured by Montreal Cognitive Assessment (MoCA) assesses several cognitive domains and is used for the screening of mild cognitive impairment. Total scores range from 0-30 with lower scores indicating decreased functioning. Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
Secondary Group differences in attention and executive functions as measured by Brief-A a standardized self-report that captures views of an adult's executive functions or self-regulation in his or her everyday environment. Postabsorptive state during 3 hours and change after feeding on study day 1 and the change from day 2 and day 3
Secondary Skeletal muscle strength handgrip and kin-com 1-leg test on study day 1 and the change from day 2 and day 3
Secondary 24 hour diet recall The subject is asked to recall in detail all the food and drink consumed during the 24 hours prior to the test day. on study day 1 and the change from day 2 and day 3
Secondary Respiratory muscle strength Maximum inhalation and exhalation pressure on study day 1 and the change from day 2 and day 3
Secondary Body Composition Body composition as measured by Dual-Energy X-ray Absorptiometry on study day 1 and the change from day 2 and day 3 on study day 1 and the change from day 2 and day 3
Secondary Gut function Digestion of the stable tracers of amino acid postabsorptive and prandial state every 20 minutes up to 6 hours before each sip feeding on day 1 and the change from day 2 and day 3
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2